Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: A meta-analysis

Acta Neurologica Scandinavica

Volumn 112, Issue 1, 2005, Pages 1-5

  Bosma, R ^a   Wynia, K ^a   Havlikova E ^b   De Keyser, J ^a   Middel, Berrie ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Bladder dysfunction; Desmopressin; Multiple sclerosis; Urinary frequency

Indexed keywords

DESMOPRESSIN;

ABDOMINAL PAIN; ANKLE EDEMA; BLADDER DYSFUNCTION; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FLUID RETENTION; HEADACHE; HUMAN; HYPONATREMIA; MEDICAL LITERATURE; META ANALYSIS; MICTURITION DISORDER; MULTIPLE SCLEROSIS; NAUSEA; PLASMA OSMOLALITY; PUBLICATION; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; URINARY FREQUENCY; URINARY HESITANCY; URINE INCONTINENCE; URINE VOLUME;

ADULT; AGED; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OSMOLAR CONCENTRATION; RENAL AGENTS; SODIUM; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINATION; WATER-ELECTROLYTE BALANCE;

EID: 20444443119     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00431.x     Document Type: Review

References (16)

1. VALIQUETTE G, HERBERT J, MEADE-DÁLISERA P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, cross over trial. Arch Neurol 1996; 53: 1270-5.
2. BAKKE A, MYHR KM, GRONNING M, NYLAND H. Bladder, bowel and sexual dysfunction in patients with multiple sclerosis. Scand J Urol Nephrol 1996; 30(Suppl.): 61-6.
3. GIANNANTONI A, SCIVOLETTO G, DISTASI SM, et al. Lower urinary tract dysfunction and disability status in patients with Multiple Sclerosis. Arch Phys Med Rehabil 1999; 80: 437-41.
4. KNUDSEN UB, RITTIG S, NORGAARD JP, LUNDEMOSE JB, PEDERSEN EB, DJURHUUS JC. Long-term treatment of nocturnal enuresis with desmopressin. A follow-up study. Urol Res 1991; 19: 237-40.
5. WESTGREN U, WITTSTROM C, HARRIS AS. Oral desmopressin in central diabetes insipidus. Arch Dis Child 1986; 61: 247-50.
6. ECKFORD SD, SWAMI KS, ABRAMS PH. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis. Br J Urol 1994; 74: 733-5.
7. FREDRIKSON S. Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis. Acta Neurol Scand 1996; 94: 31-4.
8. HOVERD PA, FOWLER CJ. Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65: 778-80.
9. KINN AC, LARSSON PO. Desmopressin: a new principle for symptomatic treatment of urgency and continence in patients with multiple sclerosis. Scand J Urol Nephrol 1990; 24: 109-12.
10. LIPSEY MW. Design sensitivity. Statistical power for experimental research. London: SAGE Publications, 1990.
11. HEDGES LV, OLKIN I. Statistical methods for meta-analysis. New York: Academic Press, 1985.
12. COHEN J. Statistical power analysis for the behavioural sciences. New York: Academic Press, 1977.
13. ROSENTHAL R, RUBIN DB. A simple, general purpose display of magnitude of experimental effect. J Educ Psychol 1982; 74: 166-9.
14. ECKFORD SD, CARTER PG, JACKSON SR, PENNEY MD, ABRAMS PH. An open, inpatient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia. Br J Urol 2003; 74: 459-63.
15. TUBRIDY N, ADDISON R, SCHON F. Long-term use of desmopressin for urinary symptoms in multiple sclerosis. Mult Scler 1999; 5: 416-7.
16. VALIQUETTE G, ABRAMS GM, HERBERT J. DDAVP in the management of nocturia in multiple sclerosis. Ann Neurol 1992; 31: 577.